These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24755623)

  • 1. Economics and financing of vaccines for diarrheal diseases.
    Bartsch SM; Lee BY
    Hum Vaccin Immunother; 2014; 10(6):1568-81. PubMed ID: 24755623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific challenges and opportunities in developing novel vaccines for the emerging and developing markets: New Technologies in Emerging Markets, October 16th-18th 2012, World Vaccine Congress, Lyon.
    Kochhar S
    Hum Vaccin Immunother; 2013 Apr; 9(4):928-31. PubMed ID: 23322007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for epidemic infections and the role of CEPI.
    Plotkin SA
    Hum Vaccin Immunother; 2017 Dec; 13(12):2755-2762. PubMed ID: 28375764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of the economic value of diarrheal vaccines.
    Rheingans R; Amaya M; Anderson JD; Chakraborty P; Atem J
    Hum Vaccin Immunother; 2014; 10(6):1582-94. PubMed ID: 24861846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for vaccine research in Europe.
    Gancberg D; Hoeveler A; Martini A; Draghia-Akli R
    Hum Vaccin Immunother; 2015; 11(8):1917-20. PubMed ID: 26090718
    [No Abstract]   [Full Text] [Related]  

  • 6. Whither vaccines?
    Rodrigues CMC; Pinto MV; Sadarangani M; Plotkin SA
    J Infect; 2017 Jun; 74 Suppl 1():S2-S9. PubMed ID: 28646957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financing children's vaccines.
    Nelson EA; Sack D; Wolfson L; Walker DG; Seng LF; Steele D
    Vaccine; 2009 Nov; 27 Suppl 5():F12-7. PubMed ID: 19931710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK.
    Fitchett JR; Head MG; Atun R
    Vaccine; 2013 Dec; 31(50):5930-3. PubMed ID: 24176489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report.
    Hosangadi D; Smith PG; Kaslow DC; Giersing BK;
    Vaccine; 2019 Nov; 37(50):7381-7390. PubMed ID: 29352598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights of the 8th International Conference on Vaccines for Enteric Diseases: the Scottish Encounter To Defeat Diarrheal Diseases.
    Tennant SM; Steele AD; Pasetti MF
    Clin Vaccine Immunol; 2016 Apr; 23(4):272-81. PubMed ID: 26936100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.
    O'Ryan M; Vidal R; del Canto F; Salazar JC; Montero D
    Hum Vaccin Immunother; 2015; 11(3):584-600. PubMed ID: 25715048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination vaccines against diarrheal diseases.
    Venkatesan MM; Van de Verg LL
    Hum Vaccin Immunother; 2015; 11(6):1434-48. PubMed ID: 25891647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine development costs: a review.
    Waye A; Jacobs P; Schryvers AB
    Expert Rev Vaccines; 2013 Dec; 12(12):1495-501. PubMed ID: 24160863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roadmap for the establishment of a European vaccine R&D infrastructure.
    Leroy O; Geels M; Korejwo J; Dodet B; Imbault N; Jungbluth S
    Vaccine; 2014 Dec; 32(51):7021-7024. PubMed ID: 25148773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human capital gaps in vaccine development: an issue for global vaccine development and global health.
    Cawein A; Emini E; Watson M; Dailey J; Donnelly J; Tresnan D; Evans T; Plotkin S; Gruber W
    Ann N Y Acad Sci; 2017 May; 1395(1):3-11. PubMed ID: 28229472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus vaccines: current status and future considerations.
    Yen C; Tate JE; Hyde TB; Cortese MM; Lopman BA; Jiang B; Glass RI; Parashar UD
    Hum Vaccin Immunother; 2014; 10(6):1436-48. PubMed ID: 24755452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control.
    Lopman BA; Steele D; Kirkwood CD; Parashar UD
    PLoS Med; 2016 Apr; 13(4):e1001999. PubMed ID: 27115709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status of vaccine research and development for enterotoxigenic Escherichia coli.
    Bourgeois AL; Wierzba TF; Walker RI
    Vaccine; 2016 Jun; 34(26):2880-2886. PubMed ID: 26988259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines: from valuation to resource allocation.
    Bloom DE; Madhavan G
    Vaccine; 2015 Jun; 33 Suppl 2():B52-4. PubMed ID: 26022569
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.